S'abonner

Predictive value of chest CT scoring in COVID-19 patients in Wuhan, China: A retrospective cohort study - 12/02/21

Doi : 10.1016/j.rmed.2020.106271 
Shu Li a, Shaoyu Liu a, Ben Wang b, Qiuyu Li c, Hua Zhang d, Lin Zeng d, Hongxia Ge a, Qingbian Ma a, Ning Shen c,
a Department of Emergency Medicine, Peking University Third Hospital, Beijing, China 
b Department of Orthopedics, Peking University Third Hospital, Beijing, China 
c Department of Pulmonary and Critical Care Medicine, Peking University Third Hospital, Beijing, China 
d Clinical Epidemiology Research Center, Peking University Third Hospital, Beijing, China 

Corresponding author. Department of Pulmonary and Critical Care Medicine, Peking University Third Hospital, No. 49 North Garden Road, Haidian District, Beijing, 100191, China.Department of Pulmonary and Critical Care MedicinePeking University Third HospitalNo. 49 North Garden RoadHaidian DistrictBeijing100191China

Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.

Connectez-vous pour en bénéficier!

Abstract

Background

Computed tomography (CT) findings of COVID-19 patients were demonstrated by cases series and descriptive studies, but quantitative analysis performed by clinical doctors and studies on its predictive value were rarely seen. The aim of the study is to analyze CT score in COVID-19 patients and explore its predictive value.

Materials and methods

We conducted a retrospective cohort study among confirmed COVID -19 patients with available CT images between February 8, 2020 and March 7, 2020. The lung was divided into six zones by the level of tracheal carina and the level of inferior pulmonary vein bilaterally on CT. Ground-glass opacity (GGO), consolidation, crazy-paving pattern and overall lung involvement were rated by Likert scale of 0–4 or binary as 0 or 1. Global severity score for each targeted pattern was calculated as total score of six zones.

Results

There were 53 patients and 137 CT scans included in the study. There were 18(34%) of the patients classified as moderate cases while 35(66%) patients were severe/critical cases. Severe/critical patients had higher CT scores in several types of abnormalities than moderate patients from the second week to the fourth week post symptom onset. Overall lung involvement score in the second week demonstrated predictive value for severity with a sensitivity of 81.0% and specificity of 69.2%.

Conclusions

Our modified semi-quantitative CT scoring system for COVID-19 patients demonstrated feasibility. Overall lung involvement score on the second week had predictive value for clinical severity and could be indicator for further treatment.

Le texte complet de cet article est disponible en PDF.

Highlights

Modified visual CT scoring system is feasible for clinical physicians.
Severe/critical patients had higher CT scores during progressive stage of disease.
CT score of patients on the second week had predictive value for severity of disease.

Le texte complet de cet article est disponible en PDF.

Keywords : COVID-19, Computed tomography, Pneumonia, Prognosis, Severity of illness


Plan


© 2020  The Authors. Publié par Elsevier Masson SAS. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 176

Article 106271- janvier 2021 Retour au numéro
Article précédent Article précédent
  • Association of inhaled and systemic corticosteroid use with Coronavirus Disease 2019 (COVID-19) test positivity in patients with chronic pulmonary diseases
  • Shu-Yi Liao, Irina Petrache, Tasha E. Fingerlin, Lisa A. Maier
| Article suivant Article suivant
  • Specific pathogens as predictors of poor long-term prognosis after hospital discharge for community-acquired pneumonia
  • Yuto Akiyama, Takashi Ishiguro, Ryuji Uozumi, Takashi Nishida, Yoichi Kobayashi, Noboru Takayanagi

Bienvenue sur EM-consulte, la référence des professionnels de santé.

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.